Clipping of news on Brazilian Culture, Law and Citizenship
 


Consumer News

Entities seek the suspension of GM maize NK 603 from Monsanto in Brazil

23/10/2012

This article was translated by an automatic translation system, and was therefore not reviewed by people.



 


Study showed a higher incidence of cancer and death in mice fed GM; product widely used in Brazil was released in 2008, based on short-term studies
 
Idec signed with other entities a letter asking the emergency suspension of the commercial release of transgenic maize NK603 in Brazil after the publication of the first long-term study on the effects of the product in the body. Check out the full document.
 
Held at the University of Caen in France, the study was conducted over two years with 200 laboratory rats. The rats were divided into three groups, each fed differently: only with maize NK603, NK603 corn treated with Roundup (the most used herbicide in the world) and with genetically modified corn not treated with Roundup. As far as the corn herbicide are owned by U.S. group Monsanto.
 
The corn in question was authorized in Brazil in 2008 and is widespread in crops and foods. Roundup is also widely used in Brazilian crops, especially GM.
 
The results showed higher mortality and frequently when consuming these two products. Females developed numerous and significant breast tumors, and pituitary and kidney problems. Males died, mostly from severe chronic hepato-renal deficiencies. The study was published on 19/9 in one of the most important international journals food toxicology, Food and Chemical Toxicology.
 
According to the coordinator of the study, Professor Gilles-Eric Séralini, the effects of NK603 maize had only been analyzed so far in periods of up to three months. In Brazil, CTNBio (National Technical Commission on Biosafety) authorizes the cultivation, sale and consumption of GM products based on short-term studies submitted by the companies who order the record.
 
The study puts an end to questions about the risks that GM foods pose to the health of the population and reveals the weakness of health and biosecurity agencies in various parts of the world responsible for the evaluation and authorization of these products.
 
Idec alert on the subject since 2007
In early October was postponed the trial should decide on an appeal of lawsuit filed in 2007 by Idec that questioned the legality of the technical report, issued by the CTNBio approved the release of another GM maize, the Milholl (Liberty Link corn), the company multinational Bayer.
 
The technical decision CTNBio who authorized the release of Milholl was subject to administrative appeal filed by ANVISA (National Health Surveillance Agency) and IBAMA (Brazilian Institute of Environment and Renewable Natural Resources), technically supporting the opposition to the release of the product genetically modified because of the precariousness of the risk assessment performed.
 
The lawsuit was declared partially admissible to cancel the permission for commercial release in North and Northeast Brazil and determine that the Union edit the norm with regard to requests for confidential information by proponents of release of GMOs (Genetically Modified Organisms). The standard should now provide access full content of the documents requested, except only the information that they have granted confidentiality.
 
No new date set for the trial.


Source: IDEC

Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.